[144] Everspin Technologies, Inc SEC Filing

Rhea-AI Filing Summary

Zeta Global Holdings Corp. (ZETA) | SEC Form 4 – 3 July 2025

Director Jeanine Silberblatt reported the grant of 9,907 Class A common shares on 1 July 2025. The award is structured as restricted stock that vests in four equal tranches: 1 July 2026, 1 Oct 2026, 1 Jan 2027 and 1 Apr 2027. No shares were sold and the transaction price is recorded at $0, indicating a compensation grant rather than an open-market purchase. Following the transaction, the director’s total beneficial ownership rises to 70,840 shares, all held directly. No derivative securities were reported.

The filing is routine board compensation, but it nonetheless increases insider equity alignment and signals continued board engagement through 2027.

Positive

• Director’s equity stake increases to 70,840 shares, enhancing alignment between board and shareholders.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine restricted-stock grant; minimal valuation impact.

The 9,907-share award (~US$95k at a US$9.50 stock price proxy) is immaterial versus Zeta’s ~200 m basic shares. Because the issuance is compensation-related at $0 cost, it generates de minimis dilution (<0.01%). No purchase signal exists, yet the absence of sales preserves a neutral-to-slightly-positive optics for investors seeking insider conviction. Overall, I view the disclosure as non-impactful to valuation or near-term trading dynamics.

Corporate Governance Specialist

TL;DR: Grant strengthens board-alignment; neutral governance risk.

Four-quarter vesting extends Silberblatt’s incentive horizon through April 2027, supporting long-term oversight. The grant is consistent with typical mid-cap tech board packages and poses no red flags around excessive compensation or timing. No 10b5-1 plan is indicated, suggesting ordinary-course granting. Governance impact is neutral; commitment signal is modestly constructive.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	12677	86512.92	22467446	07/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2025	Restricted Stock	Issuer			12677	07/01/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SANJEEV AGGARWAL 5670 W. Chandler Boulevard, Suite 130 Chandler AZ 85226	Common	07/02/2025	17327	112109.85

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many ZETA shares did Director Jeanine Silberblatt receive?

She received 9,907 restricted Class A shares on 1 July 2025.

When do the granted ZETA shares vest?

The shares vest in four equal installments on 1 Jul 2026, 1 Oct 2026, 1 Jan 2027 and 1 Apr 2027.

What is Silberblatt’s total ZETA share ownership after the grant?

Her beneficial ownership rises to 70,840 shares, held directly.

Was there any insider selling in this Form 4?

No. The filing only reports an award of restricted stock; no shares were sold.

Does the grant affect ZETA’s share count materially?

The award represents <0.01% of outstanding shares, so dilution is immaterial.